Literature DB >> 35832118

GOx-Functionalized Platelet Membranes-Camouflaging Nanoreactors for Enhanced Multimodal Tumor Treatment.

Baoan Chen1,2, Yanfei Shen2, Ying Du1,2, Shujun Wang3, Jianfeng Luan3, Meilin Zhang1,2.   

Abstract

Background: Glucose oxidase (GOx)-based starvation therapy is a new cancer treatment strategy. However, the characteristics such as limited curative effect and hypoxic tumor environment hinder its further application seriously.
Methods: Herein, doxorubicin (DOX) loaded in hollow mesoporous copper sulfide (HMCuS) nanoparticles assembled with manganese dioxide (HMMD) as nanoshell was prepared. We developed a targeted enhanced cancer treatment method to camouflage HMMD by GOx-functionalized platelet (PLT) membranes (HMMD@PG).
Results: GOx can be specially transported to the tumor site with PLT membrane for effective starvation treatment. Glucose and oxygen (O2) in the tumor were converted to H2O2 under the catalysis of GOx. HMMD can catalyze H2O2 to produce O2 and consume glutathione (GSH) in time, which regulates the tumor microenvironment (TME) and improves the adverse conditions of anti-tumor. In addition, DOX encapsulated in HMCuS-MnO2 release was accelerated from the nanoparticles after the "gatekeeper" MnO2 is consumed. The study of anti-tumor mechanism shows that the remarkable tumor suppressive ability of HMMD@PG comes from the three peaks synergy of starvation treatment, photothermal treatment (PTT), and chemotherapy. This nanoplatform disguised by PLT membrane has significant tumor inhibition ability, good biocompatibility and almost has no side effects in main organs.
Conclusion: This work broadens the application mode of GOx and shows the new development of a multi-mode collaborative processing system of nanoplatforms based on cell membrane camouflage.
© 2022 Du et al.

Entities:  

Keywords:  PLT membrane; glucose oxidase; nanoparticles; tumor microenvironment; tumor treatment

Mesh:

Substances:

Year:  2022        PMID: 35832118      PMCID: PMC9273187          DOI: 10.2147/IJN.S358138

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  33 in total

1.  Biomimetic nanoreactor for targeted cancer starvation therapy and cascade amplificated chemotherapy.

Authors:  Fengying Shao; Yafeng Wu; Zhaoyan Tian; Songqin Liu
Journal:  Biomaterials       Date:  2021-05-07       Impact factor: 12.479

2.  Dopamine-melanin colloidal nanospheres: an efficient near-infrared photothermal therapeutic agent for in vivo cancer therapy.

Authors:  Yanlan Liu; Kelong Ai; Jianhua Liu; Mo Deng; Yangyang He; Lehui Lu
Journal:  Adv Mater       Date:  2012-12-21       Impact factor: 30.849

3.  Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy.

Authors:  Lian-Hua Fu; Yilin Wan; Chao Qi; Jin He; Chunying Li; Chen Yang; Han Xu; Jing Lin; Peng Huang
Journal:  Adv Mater       Date:  2021-01-04       Impact factor: 30.849

4.  A Hollow-Structured CuS@Cu2 S@Au Nanohybrid: Synergistically Enhanced Photothermal Efficiency and Photoswitchable Targeting Effect for Cancer Theranostics.

Authors:  Xiaoran Deng; Kai Li; Xuechao Cai; Bin Liu; Yi Wei; Kerong Deng; Zhongxi Xie; Zhijian Wu; Ping'an Ma; Zhiyao Hou; Ziyong Cheng; Jun Lin
Journal:  Adv Mater       Date:  2017-07-26       Impact factor: 30.849

5.  Tumor microenvironment responsive hollow mesoporous Co9S8@MnO2-ICG/DOX intelligent nanoplatform for synergistically enhanced tumor multimodal therapy.

Authors:  Junqing Huang; Yao Huang; Zhenluan Xue; Songjun Zeng
Journal:  Biomaterials       Date:  2020-09-03       Impact factor: 12.479

Review 6.  Targeting the tumor microenvironment for cancer therapy.

Authors:  Nor Eddine Sounni; Agnès Noel
Journal:  Clin Chem       Date:  2012-11-28       Impact factor: 8.327

Review 7.  Glutathione metabolism in cancer progression and treatment resistance.

Authors:  Ankita Bansal; M Celeste Simon
Journal:  J Cell Biol       Date:  2018-06-18       Impact factor: 10.539

Review 8.  NIR fluorescence-guided tumor surgery: new strategies for the use of indocyanine green.

Authors:  Claire Egloff-Juras; Lina Bezdetnaya; Gilles Dolivet; Henri-Pierre Lassalle
Journal:  Int J Nanomedicine       Date:  2019-09-25

9.  Biodegradable hollow mesoporous organosilica nanotheranostics (HMON) for multi-mode imaging and mild photo-therapeutic-induced mitochondrial damage on gastric cancer.

Authors:  Weihong Guo; Zhian Chen; Jiajia Chen; Xiaoli Feng; Yang Yang; Huilin Huang; Yanrui Liang; Guodong Shen; Yu Liang; Chao Peng; Yanbing Li; Guoxin Li; Wenhua Huang; Bingxia Zhao; Yanfeng Hu
Journal:  J Nanobiotechnology       Date:  2020-07-20       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.